Anti-MUC13/ DRCC1/ MUC-13 monoclonal antibody
Anti-MUC13/ DRCC1/ MUC-13 antibody for FACS & in-vivo assay
Go to MUC13/MUC13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0854-Ab-1/ GM-Tg-hg-MP0854-Ab-2 | Anti-Human MUC13 monoclonal antibody | Human |
GM-Tg-rg-MP0854-Ab-1/ GM-Tg-rg-MP0854-Ab-2 | Anti-Rat MUC13 monoclonal antibody | Rat |
GM-Tg-mg-MP0854-Ab-1/ GM-Tg-mg-MP0854-Ab-2 | Anti-Mouse MUC13 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0854-Ab-1/ GM-Tg-cynog-MP0854-Ab-2 | Anti-Cynomolgus/ Rhesus macaque MUC13 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0854-Ab-1/ GM-Tg-felg-MP0854-Ab-2 | Anti-Feline MUC13 monoclonal antibody | Feline |
GM-Tg-cang-MP0854-Ab-1/ GM-Tg-cang-MP0854-Ab-2 | Anti-Canine MUC13 monoclonal antibody | Canine |
GM-Tg-bovg-MP0854-Ab-1/ GM-Tg-bovg-MP0854-Ab-2 | Anti-Bovine MUC13 monoclonal antibody | Bovine |
GM-Tg-equg-MP0854-Ab-1/ GM-Tg-equg-MP0854-Ab-2 | Anti-Equine MUC13 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0854-Ab-1/ GM-Tg-hg-MP0854-Ab-2; GM-Tg-rg-MP0854-Ab-1/ GM-Tg-rg-MP0854-Ab-2; GM-Tg-mg-MP0854-Ab-1/ GM-Tg-mg-MP0854-Ab-2; GM-Tg-cynog-MP0854-Ab-1/ GM-Tg-cynog-MP0854-Ab-2; GM-Tg-felg-MP0854-Ab-1/ GM-Tg-felg-MP0854-Ab-2; GM-Tg-cang-MP0854-Ab-1/ GM-Tg-cang-MP0854-Ab-2; GM-Tg-bovg-MP0854-Ab-1/ GM-Tg-bovg-MP0854-Ab-2; GM-Tg-equg-MP0854-Ab-1/ GM-Tg-equg-MP0854-Ab-2 |
Products Name | Anti-MUC13 monoclonal antibody |
Format | mab |
Target Name | MUC13 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-MUC13 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species MUC13/ DRCC1/ MUC-13 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLPm002770 | mouse Muc13 Lentivirus plasmid |
ORF Viral Vector | vGMLPm002770 | mouse Muc13 Lentivirus particle |
Target information
Target ID | GM-MP0854 |
Target Name | MUC13 |
Gene ID | 56667,17063,207126,716407,478594,101101499,100295610,100070362 |
Gene Symbol and Synonyms | 114/A10,14/A10,DRCC1,Lrrp,Ly64,Muc-123,MUC-13,MUC13,NJ-1 |
Uniprot Accession | Q9H3R2,P97881 |
Uniprot Entry Name | MUC13_HUMAN,MUC13_RAT |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000173702 |
Target Classification | N/A |
The target: MUC13, gene name: MUC13, also named as DRCC1, MUC-13. Epithelial mucins, such as MUC13, are a family of secreted and cell surface glycoproteins expressed by ductal and glandular epithelial tissues (Williams et al., 2001 [PubMed 11278439]).[supplied by OMIM, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.